What does the evidence say about Lutein Visual Fatigue Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Lutein Visual Fatigue Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - This systematic review aimed to evaluate randomized controlled trial (RCT) evidence on the effects of carotenoids, anthocyanins, polyunsaturated fatty acids, and combined nutraceutical formulations on refractive outcomes, axial length, macular pigment optical density (MPOD), visual function, and symptoms of visual fatigue. [Martinez-Perez C (2025); evidence level 1] - Eligible studies were RCTs involving individuals with myopia or at risk of myopia, comparing nutritional supplementation with placebo or active controls. [Martinez-Perez C (2025); evidence level 1] - Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Cochrane RoB 2 tool. [Martinez-Perez C (2025); evidence level 1] - Background/objectives Nutritional supplementation has been proposed as a potential adjunct strategy in myopia prevention and control through antioxidative, anti-inflammatory, and extracellular matrix-regulating mechanisms. [Martinez-Perez C (2025); evidence level 1] - 7 9 The standard of care for many IRDs has largely focused on managing associated complications and the use of optical aids to improve quality of life. [Barthelemy Normila (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.